1. Presidential address at the European Society for Medical Oncology, Nice, 30 November 1986

   • Silvio Monfardini

   Medical Oncology Pages: 179 - 184

2. Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product

   • Shogo Ozawa
   • Yuichi Sugiyama
   • Makoto Inaba

   Original Articles Pages: 185 - 190

3. Potentiation of platinum analogue cytotoxicity by hyperthermia

   • Min Jian Xu
   • David S. Alberts

   Original Articles Pages: 191 - 196

4. The disposition of carboplatin in the beagle dog

   • Robert C. Gaver
   • Alice M. George
   • Raymond H. Farmen

   Original Articles Pages: 197 - 202

5. Cytogenetic effect of carboplatin on human lymphocytes

   • Tetsu Shinkai
   • Nagahiro Saijo
   • Takashi Nakajima

   Original Articles Pages: 203 - 207

6. DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells

   • John D. Schuetz
   • Hugh J. Wallace
   • Robert B. Diasio

   Original Articles Pages: 208 - 210

7. Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays

   • Andrew G. Bosanquet
   • Martin C. Bird

   Original Articles Pages: 211 - 215

8. HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids

   • Carlo M. Camaggi
   • Raffaella Comparsi
   • Franco Pannuti

   Original Articles Pages: 216 - 220

9. Epirubicin and doxorubicin comparative metabolism and pharmacokinetics

   • Carlo M. Camaggi
   • Raffaella Comparsi
   • Franco Pannuti

   Original Articles Pages: 221 - 228

10. Effect of hyperthermia and doxorubicin on nucleoid sedimentation and poly (ADP-ribose) Polymerase activity in L1210 cells

    • J. Patrick Daugherty
    • Thomas A. Simpson Jr.
    • Dail W. Mullins Jr.

    Original Articles Pages: 229 - 232

11. In vitro antiproliferative activity of 2′-(2-hydroxyphenyl)-2′-thiazoline-4′-carboxylic acid and its methyl ester of L1210 and P388 murine neoplasms

    • Gary T. Elliot
    • Ken F. Kelly
    • E. Robert Burns

    Original Articles Pages: 233 - 236

12. Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice

    • G. Pratesi
    • L. Gianni
    • F. Zunino

    Original Articles Pages: 237 - 240

13. Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes

    • Gianni Sava
    • Sonia Zorzet
    • Lucia Lassiani

    Original Articles Pages: 241 - 245

14. Study of histamine release induced by acute administration of antitumor agents in dogs

    • Alain Eschalier
    • Jeannine Lavarenne
    • Maria Rodriguez

    Original Articles Pages: 246 - 250

15. Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin

    • Rosanna Supino
    • Mariangela Mariani
    • Giorgio Parmiani

    Original Articles Pages: 251 - 254

16. Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy

    • Mark D. Vincent
    • Trevor J. Powles
    • T. J. McElwain

    Original Articles Pages: 255 - 260

17. Phase II trial of idarubicin in patients with advanced lymphoma

    • Helen Gillies
    • Raymond Liang
    • Stephen Johnson

    Original Articles Pages: 261 - 264

18. Renal impairment following the combined use of high-dose methotrexate and procarbazine

    • P. Price
    • H. Thompson
    • H. J. G. Bloom

    Original Articles Pages: 265 - 267

19. Uridine induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites

    • G. J. Peters
    • C. J. van Groeningen
    • H. M. Pinedo

    Erratum Pages: 268 - 268